National Registry of Diseases Office, Health Promotion Board, Singapore.
Ann Acad Med Singap. 2019 Mar;48(3):75-85.
This study aimed to compare the incidence and mortality of ST-segment elevation myocardial infarction (STEMI) across the 3 main ethnic groups in Singapore, determine if there is any improvement in trends over the years and postulate the reasons underlying the ethnic disparity.
This study consisted of 16,983 consecutive STEMI patients who sought treatment from all public hospitals in Singapore from 2007 to 2014.
Compared to the Chinese (58 per 100,000 population in 2014), higher STEMI incidence rate was consistently observed in the Malays (114 per 100,000 population) and Indians (126 per 100,000 population). While the incidence rate for the Chinese and Indians remained relatively stable over the years, the incidence rate for the Malays rose slightly. Relative to the Indians (30-day and 1-year all-cause mortality at 9% and 13%, respectively, in 2014), higher 30-day and 1-year all-cause mortality rates were observed in the Chinese (15% and 21%) and Malays (13% and 18%). Besides the Malays having higher adjusted 1-year all-cause mortality, all other ethnic disparities in 30-day and 1-year mortality risk were attenuated after adjusting for demographics, comorbidities and primary percutaneous coronary intervention.
It is important to continuously evaluate the effectiveness of existing programmes and practices as the aetiology of STEMI evolves with time, and to strike a balance between prevention and management efforts as well as between improving the outcome of "poorer" and "better" STEMI survivors with finite resources.
本研究旨在比较新加坡 3 大主要种族群体的 ST 段抬高型心肌梗死(STEMI)的发病率和死亡率,确定近年来趋势是否有所改善,并推测种族差异的背后原因。
本研究纳入了 2007 年至 2014 年期间在新加坡所有公立医院就诊的 16983 例连续 STEMI 患者。
与华人(2014 年每 10 万人中有 58 例)相比,马来人(每 10 万人中有 114 例)和印度人(每 10 万人中有 126 例)的 STEMI 发病率一直较高。尽管华人及印度人的发病率多年来相对稳定,马来人的发病率却略有上升。与印度人(2014 年的 30 天和 1 年全因死亡率分别为 9%和 13%)相比,华人(30 天和 1 年全因死亡率分别为 15%和 21%)和马来人(30 天和 1 年全因死亡率分别为 13%和 18%)的 30 天和 1 年全因死亡率更高。除了马来人调整后 1 年全因死亡率较高外,调整人口统计学、合并症和直接经皮冠状动脉介入治疗后,其他所有种族在 30 天和 1 年死亡率风险方面的差异均减弱。
随着 STEMI 的病因随时间演变,必须不断评估现有计划和实践的有效性,并在有限的资源下,在预防和管理工作之间以及在改善“较差”和“较好”STEMI 幸存者的预后之间取得平衡。